Sigma-Chemist Warehouse deal secures ACCC approval
Sigma Healthcare (ASX:SIG) has announced that its proposed merger with Chemist Warehouse Group is not opposed by the Australian Competition and Consumer Commission.
Read More
Sigma Healthcare is a leading Australian full line wholesale and distribution business to community and hospital pharmacy.
Sigma Healthcare have the largest pharmacy network in Australia, with over 1,200 branded and independent stores. Sigma also has an expanding presence in the hospital pharmacy services and other healthcare service adjacencies.
From modest beginnings in Melbourne in 1912, the company has grown into a vibrant, nationwide network servicing community and hospital pharmacy. We are proud of our role in helping to make pharmacy services and medicines accessible for all Australians.
Sigma Healthcare are here to serve our communities by:
Sigma Healthcare (ASX:SIG) has announced that its proposed merger with Chemist Warehouse Group is not opposed by the Australian Competition and Consumer Commission.
Read More
Shares in Sigma Healthcare (ASX:SIG) jumped more than 25% yesterday after the ACCC invited submissions. This was in relation to the pharmacy wholesaler's proposed court-enforceable undertaking regarding its $700+ million acquisition of Chemist Warehouse.
Read More
Pharmacy wholesaler and retailer Sigma Healthcare (ASX:SIG) says its significant drop in interim earnings is due to ongoing costs associated with the impending merger with retail chain Chemist Warehouse.
Read More
Sigma Healthcare (ASX:SIG) shares fell more than 9% at one stage on Thursday after its proposed $8.8 billion merger with the massive Chemist Warehouse encountered potential competition issues with the key regulator, the ACCC.
Read More
The competition regulator, the ACCC, has raised questions about the planned $8.8 billion backward merger between Sigma Healthcare and Chemists Warehouse, citing ‘competition concerns’.
Read More
Private-owned Chemist Warehouse is set to become an ASX 200 top company through its backward takeover of Sigma Healthcare (ASX:SIG), creating a company valued at an estimated $8.8 billion.
Read More
Sigma Healthcare is paying a tiny half a cent per share final dividend after it slashed debt, boosted revenues and swung back to a small profit for the year to the end of January.
Read More
Investors in Sigma Healthcare reacted negatively to yesterday’s half year results, details of a major change in strategy and bare bones interim dividend to shareholders.
Read More
The broker retains its Neutral rating and increases its target price to $0.52 from $0.50.
Read More
Despite a weak 2021-22 annual result, Sigma Healthcare believes it is in the final phase of its reboot and ready to show that it has overcome the problems that have been dogging it.
Read More